Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b680f557d78c03e6b798bdaf8d63002 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2014-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39cde6b02f1048e18b0268d6e0d67aa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a3711ad3a34e5cf18ff0b683518fb0 |
publicationDate |
2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014119725-A1 |
titleOfInvention |
Method for reducing false negatives in immunoassay for assaying biomembrane-derived specimen |
abstract |
The present invention addresses the problem of regulating the action of an immunoassay inhibitory substance contained in a biomembrane-derived specimen and thus accurately and specifically detecting a target substance. An immunoassay method for assaying a target substance in a biomembrane-derived specimen, wherein false negatives can be reduced by treating the specimen with a specimen-treating solution which contains a compound having two or more sulfate groups. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106053792-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3373005-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106053792-A |
priorityDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |